Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05749146 · ClinicalTrials.gov registry record · NA

Palliative Care for Patients With Dementia

A NA study of Dementia, sponsored by Icahn School of Medicine at Mount Sinai.

Active
Registry status
NA
Development phase
153
Enrollment target
1
Study location

NCT05749146 is a NA study of Dementia that is active but no longer recruiting, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 153 participants, below the 7,722-participant average among 199 other Dementia trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05749146, a NA study of Dementia, is active but no longer recruiting, sponsored by Icahn School of Medicine at Mount Sinai.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
153 participants
Enrollment target
1
Study location

Study Summary

A multi-site, single-blinded, parallel, randomized-controlled trial to evaluate the effectiveness of a novel model of in-home palliative care for dementia patients and their family caregivers. From inpatient and outpatient settings associated with four hospitals across New York City, patients with advanced dementia and their family caregivers will be randomized to intervention or augmented control.

Conditions Studied

Interventions

  • BEHAVIORAL Home Palliative Care

Study Locations (1)

New York

  • Ichan School of Medicine at Mount Sinai - New York

Trial Details

FieldValue
Enrollment Target 153 participants
Start Date 2023-06-08
Est. Completion 2027-03-15
Phase NA

What the Registry Record Tells You About NCT05749146

The ClinicalTrials.gov registry entry for NCT05749146 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 153 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 7,722-participant average among 199 other Dementia trials with a reported enrollment target (98% lower). The listed sponsor is Icahn School of Medicine at Mount Sinai, which has 708 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Dementia appearing as the primary indexed condition, and to 1 intervention - of which Home Palliative Care is the first listed.

NCT05749146 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT05749146 about?

NCT05749146 is a clinical study titled "Palliative Care for Patients With Dementia". A multi-site, single-blinded, parallel, randomized-controlled trial to evaluate the effectiveness of a novel model of in-home palliative care for dementia patients and their family caregivers. From inpatient and outpatient settings associated with four hospitals across New York City, patients with a...

What is the current status of trial NCT05749146?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 153 participants. The study started on 2023-06-08. Estimated completion is 2027-03-15.

What conditions does trial NCT05749146 study?

This clinical trial studies the following conditions: Dementia.

What interventions are being tested in trial NCT05749146?

The interventions under investigation include: Home Palliative Care (BEHAVIORAL).

Who is sponsoring clinical trial NCT05749146?

This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05749146 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Dementia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.